Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings

International Journal of Gynecology and Obstetrics

Volumn 97, Issue 1, 2007, Pages 52-56

  Bradley, S E K ^a   Prata, N ^b,c   Young Lin, N ^c   Bishai, D M ^d  

^a Constella Futures ^*  (United States)

^b Bixby Program in Population Family Planning and Maternal Health   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost effectiveness; Maternal morbidity; Postpartum hemorrhage, misoprostol; Traditional birth attendants

Indexed keywords

MISOPROSTOL;

ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG COST; FEMALE; HEALTH CARE COST; HIGH TEMPERATURE; HOSPITAL EQUIPMENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; SHIVERING; SIDE EFFECT; SWEATING; TRANSFUSION; VOMITING;

EID: 33847670259     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.12.005     Document Type: Article

References (26)

1. Tsu V., Langer A., and Aldrich T. Postpartum hemorrhage in developing countries: is the public health community using the right tools?. Int J Gynecol Obstet 85 (2004) S42-S51
2. Miller S., Lester F., and Hensleigh P. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. J Midwifery Womens Health 49 4 (2004) 283-292
3. WHO, UNFPA, and UNICEF. Definition of traditional birth attendant, joint statement (1992), World Health Organization, Geneva
4. Schaider J., Ngonyani S., Tomlin S., Rydman R., and Roberts R. International maternal mortality reduction: outcome of traditional birth attendant education and intervention in Angola. J Med Syst 23 2 (1999) 99-105
5. World Health Organization. Making pregnancy safer: the critical role of the skilled attendant (2004), WHO, Geneva
6. Bugalho A., Daniel A., Faundes A., and Cunha M. Misoprostol for prevention of postpartum hemorrhage. Int J Gynecol Obstet 73 1 (2001) 1-6
7. Hofmeyr G.J., Walraven G., Gulmezoglu A.M., Maholwana B., Alfirevic Z., and Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 112 5 (2005) 547-553
8. Sanghvi H., Wiknjosastro G., Chanpoing G., Fishel J., and Ahmed S. Prevention of postpartum hemorrhage study: West Java, Indonesia (2004), JHPIEGO, Baltimore, MD
9. Kadanali S., Kucukozkan T., Zor N., and Kumtepe Y. Comparison of labor induction with misoprostol vs. oxytocin/prostaglandin E2 in term pregnancy. Int J Gynecol Obstet 55 2 (1996) 99-104
10. Gulmezoglu A.M., Villar J., Ngoc N.T., Piaggio G., Carroli G., Adetoro L., et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358 9283 (2001) 689-695
11. Hofmeyr G.J., Ferreira S., Nikodem V.C., Mangesi L., Singata M., Jafta Z., et al. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]. BMC Pregnancy Childbirth 4 1 (2004) 16
12. Karkanis S.G., Caloia D., Salenieks M.E., Kingdom J., Walker M., Meffe F., et al. Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynaecol Can 24 2 (2002) 149-154
13. Prata N., Mbaruku G., Campbell M., Potts M., and Vahidnia F. Controlling postpartum hemorrhage after home births in Tanzania. Int J Gynecol Obstet 90 1 (2005) 51-55
14. World Health Organization. Choosing interventions that are cost effective (WHO-CHOICE) (2005)
15. Creinin M.D., Shore E., Balasubramanian S., and Harwood B. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion. Contraception 71 1 (2005) 26-30
16. Potts M., and Campbell M. Three meetings and fewer funerals-misoprostol in postpartum haemorrhage. Lancet 364 9440 (2004) 1110-1111
17. Walraven G., Dampha Y., Bittaye B., Sowe M., and Hofmeyr J. Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial. BJOG 111 9 (2004) 1014-1017
18. Strand R.T., Da Silva F., Jangsten E., and Bergstrom S. Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration. Acta Obstet Gynecol Scand 84 3 (2005) 260-265
19. AbouZahr C. Global burden of maternal death and disability. Br Med Bull 67 (2003) 1-11
20. Fauveau V., Stewart K., Khan S.A., and Chakraborty J. Effect on mortality of community-based maternity-care programme in rural Bangladesh. Lancet 338 8776 (1991) 1183-1186
21. World Health Organization. Care of mother and baby at the health centre: A practical guide. 2nd Revision. WHO/FHE/MSM/94.2 ed. Geneva: WHO, 1997.
22. Assistance Afghanistan. 1999 Appeal for Afghanistan Profile of Submissions under Thematic Group. Assistance Afghanistan, 1999.
23. AIM for SEVA. Proposal for maternal and child health care along with mobile dispensary. All Indian movement for Seva (2005)
24. Adam T., Evans D., and Murray C. Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc 1 1 (2003) 3
25. World Health Organization. Mother-baby package costing spreadsheet (1999), WHO, Geneva
26. Hensher M., and Jefferys E. Financing blood transfusion services in sub-Saharan Africa: a role for user fees?. Health Policy Plan 15 3 (2000) 287-295